Lifeward Ltd. Ordinary Shares
LFWDLifeward Ltd. is a company specializing in the development and provision of medical and health-related technologies. Its focus includes innovative solutions aimed at improving patient care and healthcare efficiency. The company engages in the design, manufacturing, and deployment of products and services within the healthcare sector, emphasizing advancements in health monitoring and safety.
Company News
Lifeward Ltd. announced the appointment of Dr. Keith D. Rose as Chief Medical Officer, promoting him from his previous role as Vice President of Medical Affairs. With 30 years of rehabilitation medicine experience, Dr. Rose will lead the company's global medical strategy as Lifeward expands its neurorehabilitation portfolio and advances its biome...
Lifeward Ltd. announced shareholder approval for a strategic partnership with Oramed Pharmaceuticals, integrating Oramed's POD™ oral delivery technology platform. The deal provides Lifeward with up to $47 million in capital while allowing the company to diversify from its core medical technology business into biotechnology. Oramed will manage a...
Lifeward Ltd. (Nasdaq: LFWD) announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 or more for at least 10 consecutive business days, achieved on March 9, 2026. The company's common stock will continue trading on The Nasdaq Capital Market. Lifeward is a medical technology company specializing in physical rehabi...
Lifeward announced that Aetna has approved Medicare Advantage coverage for its ReWalk Personal Exoskeleton, joining Humana and UnitedHealthcare. The three insurers collectively represent approximately 16 million beneficiaries, significantly expanding access to the FDA-approved exoskeleton technology for individuals with spinal cord injuries.
Lifeward Ltd. announced the appointment of Almog Adar as its new Chief Financial Officer, promoting him from his previous role as Vice President of Finance and Chief Accounting Officer.
